Disseminated morphea in small cell lung cancer

Benekli, Mustafa; Yalcin, Basak; Guler, Nilufer; Tekuzman, Gulten
April 1998
Acta Dermato-Venereologica;4/20/98, Vol. 78 Issue 1, p71
Academic Journal
Describes a case of disseminated morphea in small cell lung cancer. Case background; Emergence of sclerotic skin changes in the absence of systemic involvement; Distinct paraneoplastic manifestation of small cell lung cancer.


Related Articles

  • Erlotinib.  // Reactions Weekly;10/5/2013, Issue 1472, p19 

    An abstract of the article "High-dose, pulsatile erlotinib in two NSCLC patients with leptomeningeal metastases-One with a remarkable thoracic response as well," by J. L. Kuiper and colleagues is presented.

  • Skin Metastases from Small-Cell Carcinoma of the Lung. Fox, Joshua L.; Berman, Brian; Prioleau, Philip G. // Journal of Dermatologic Surgery & Oncology;Jun83, Vol. 9 Issue 6, p451 

    This paper reports the first case of skin metastases from small-cell carcinoma of the lung with electron microscopic confirmation. The 2 to 3-cm cutaneous lesions present on the chest and limbs were hard, nontender, smooth-surfaced, freely moveable nodules with normal appearing overlying skin....

  • Erlotinib.  // Reactions Weekly;6/7/2008, Issue 1205, p11 

    The article describes the case of a 58-year-old man who developed skin eruption, conjunctivitis and diarrhoea and later experienced eardrum perforation after taking erlotinib for non-small-cell lung cancer (NSCLC). He experienced sudden bilateral hearing loss, 12 months after taking erlotinib....

  • Dermatomyositis as an early manifestation and a significant clinical precursor of lung cancer: report of a rare case and review of the current literature. Nikolaos, Tsoukalas; Maria, Tolia; Ioannis, Kostakis D.; Georgios, Lypas; Nikolaos, Pistamaltzian; Stamatina, Demiri; Christos, Panopoulos; Georgios, Koumakis; Vasileios, Barbounis; Anna, Efremidis // International Journal of Clinical & Experimental Medicine;2013, Vol. 6 Issue 2, p105 

    Dermatomyositis represents an idiopathic inflammatory connective-tissue disease, characterized by inflammation of the muscles and the skin. There is a high incidence of malignancy in patients with dermatomyositis. The main purpose of the present paper is to describe and underline the clinical...

  • Erlotinib.  // Reactions Weekly;6/14/2008, Issue 1206, p13 

    The article describes two cases of skin eruption related to oral erlotinib administration. Both patients are aged, who were diagnosed with metastatic non-small cell lung cancer. The first patient is a 41-year-old woman who complained of papulopustular eruption on the dorsal side of her forearms....

  • Erlotinib.  // Reactions Weekly;1/12/2008, Issue 1184, p17 

    The article describes the case of a 43-year-old man with non-small cell lung cancer who developed a typical acneiform skin eruption on his trunk, face and upper extremities, after receiving erlotinib. Findings of skin biopsies from the affected nonirradiated skin showed suppurative folliculitis...

  • Erratum to: RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China. Qiang Lin; Junfeng Geng; Kelong Ma; Jian Yu; Jinfeng Sun; Zhenya Shen; Guoliang Bao; Yinming Chen; Hongyu Zhang; Yinghua He; Xiaoying Luo; Xu Feng; Jingde Zhu // Journal of Cancer Research & Clinical Oncology;Jan2010, Vol. 136 Issue 1, p171 

    A correction to the article "RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China," which appeared in a previous issue, is presented.

  • Erlotinib.  // Reactions Weekly;2/5/2011, Issue 1337, p18 

    The article describes several cases of women who developed cosmetic hair alterations while receiving treatment with erlotinib for non-small cell lung cancer.

  • New guidance from NICE.  // PharmacoEconomics & Outcomes News;10/3/2009, Issue 588, p2 

    The article presents the guidelines for the treatment of psoriasis in adults, non-small-cell lung cancer (NSCLC) and gastrointestinal stromal tumours (GISTs) from Great Britain National Institute for Health and Clinical Excellence (NICE). The use of ustekinumab is recommended if the person has...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics